0 Comentários
0 Compartilhamentos
598 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Feed de notícias
- EXPLORAR
-
Páginas
-
Grupos
-
Eventos
-
Reels
-
Blogs
-
Marketplace
-
Offers
-
Jobs
-
Faça o login para curtir, compartilhar e comentar!
-
Veterinary Biologics Market Growth: Opportunities in Monoclonal Antibodies and Emerging MarketsThe management of animal diseases is evolving rapidly, driven by technological breakthroughs in biotechnology and a growing global emphasis on preventive animal healthcare. This is creating significant opportunities for the Veterinary Biologics Market Growth. The market is projected to expand from USD 2.72 billion in 2025 to USD 3.51 billion by 2030, driven by the emergence of monoclonal...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Antibody Discovery Market Forecast Driven by Rising Demand for Biologics by 2030The global antibody discovery market is benefiting from the development of bispecific and multispecific antibodies. These engineered molecules can interact with multiple targets, creating opportunities for novel therapeutic approaches in oncology, immunology, and other treatment areas. The antibody discovery market was valued at US$ 2.94 billion in 2022 and is projected to reach US$ 4.92...0 Comentários 0 Compartilhamentos 179 Visualizações 0 Anterior
-
Biologics and Injectable Drug Production Drive Growth in the Sterility Testing MarketAccording to a new report by Polaris Market Research, the global sterility testing market was valued at USD 1,104.65 million in 2023 and is projected to reach USD 2,387.31 million by 2032, expanding at a CAGR of 9% over the forecast period. Growth is underpinned by rising biopharmaceutical output, expanding regulatory requirements, and accelerating automation across pharmaceutical and...0 Comentários 0 Compartilhamentos 602 Visualizações 0 Anterior
-
Biologics and the Cutaneous Fibrosis Treatment Market: Targeting the Fibrotic PathwayFibrosis is driven by complex biological pathways — TGF-beta signalling, connective tissue growth factor (CTGF), and immune dysregulation among them. Biologics that target these pathways offer the potential to slow or reverse fibrosis, and they are reshaping the cutaneous fibrosis treatment market. Biologic therapies — including monoclonal antibodies and fusion proteins — aim...0 Comentários 0 Compartilhamentos 184 Visualizações 0 Anterior
-
Biologics and the Transformation of Lupus TreatmentBiologics are transforming lupus treatment—targeting specific immune pathways to reduce inflammation and organ damage. These therapies offer hope for patients with severe disease. Biologics are the fastest-growing segment of the lupus market, reflecting their clinical importance. Within the Lupus Market, biologics are growing rapidly. Belimumab and anifrolumab are leading therapies;...0 Comentários 0 Compartilhamentos 74 Visualizações 0 Anterior
-
Biologics and the Treatment of Severe Airway DiseaseFor severe asthma and airway hyperreactivity, biologics offer targeted treatment—addressing specific inflammatory pathways. These therapies are reshaping the bronchial hyperreactivity market. Within the Bronchial Hyperreactivity Market, biologics are the fastest-growing segment. Geographically, adoption is strongest in advanced markets. Looking ahead, biologics will grow. For...0 Comentários 0 Compartilhamentos 39 Visualizações 0 Anterior
-
Biologics Are Transforming the WAIHA MarketBiologics are revolutionising the treatment of warm autoimmune hemolytic anemia (WAIHA), offering new options for patients who do not respond adequately to traditional therapies such as corticosteroids and immunosuppressants. Rituximab, a monoclonal antibody targeting CD20, has become a standard second-line therapy for WAIHA, demonstrating significant efficacy in reducing hemolysis and...0 Comentários 0 Compartilhamentos 428 Visualizações 0 Anterior
-
Biologics Contract Manufacturing Market Trends Driving the Future of Biopharmaceutical ProductionThe Biologics Contract Manufacturing Market is poised for exceptional growth from 2025 to 2033, fueled by the booming biopharmaceutical industry, the rising complexity of biologic drugs, and the strategic shift of pharmaceutical companies toward outsourcing to reduce costs and accelerate commercialization. The market is projected to be valued at approximately USD 23.6...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Biologics Manufacturing Market: Innovative Bioprocessing Technologies Creating New OpportunitiesMarket Overview Polaris Market Research’s latest research report, titled Biologics Manufacturing Market, offers a comprehensive and data-driven analysis of the market landscape. Designed for decision-makers, strategists, and industry participants, this in-depth study offers critical insights into current trends, market dynamics, competitive strategies, and growth projections. In a...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Biologics Manuuring Market Growth, Company Revenue Share, Key Drivers & Trend Analysis By Fact.MRRockville, Maryland — October 28, 2026 The global biologics manufacturing market is projected to reach USD 225.52 billion by 2036, increasing from USD 46.92 billion in 2026 at a compound annual growth rate (CAGR) of 17.0%, according to Fact.MR. The market is expected to create an incremental opportunity of USD 178.60 billion over the forecast period, highlighting the expanding commercial...0 Comentários 0 Compartilhamentos 214 Visualizações 0 Anterior
-
Biologics Market Expands Amid Rising Demand for Innovative Treatment SolutionsAccording to the latest market intelligence report published by Future Market Insights (FMI), the global biologics market is projected to grow from USD 450.2 billion in 2025 to USD 1,077.2 billion by 2035, registering a compound annual growth rate (CAGR) of 9.1% between 2025 and 2035. Rising demand for targeted therapies, increasing chronic disease prevalence, advances in biotechnology, and...0 Comentários 0 Compartilhamentos 201 Visualizações 0 Anterior
-
Clinical Trial Supplies Market Opportunities in Decentralized ResearchThe global Clinical Trial Supplies Market was valued at USD 5.7 billion in 2025 and is projected to reach USD 10.7 billion by 2033, expanding at a CAGR of 8.4% from 2026 to 2033. The market is being reshaped by rising pharmaceutical R&D investments, increasing clinical trial complexity, the globalization of research, and the growing development of biologics and personalized...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Healthcare Contract Development and Manufacturing Organization Market Forecast Shows Strong Industry ExpansionA new medicine does not reach the market through research alone. Between discovering a promising compound and producing a commercially available therapy lies a long chain of development, testing, formulation, manufacturing, quality control, regulatory work, and supply management. As pharmaceutical and biotechnology companies build increasingly complex pipelines, many are choosing not to develop...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Injectable Targeted Therapy Market Size, Share, Trends & Forecast 2033According to the latest report published by Data Bridge Market Research, the Injectable Targeted Therapy Market CAGR Value Injectable Targeted Therapy Market survey report is intended to help the readers develop a practical and intelligent approach to market dynamics and exploit opportunities, therefore. The market report also contains the drivers and restraints for the...0 Comentários 0 Compartilhamentos 808 Visualizações 0 Anterior
-
Nanobody Therapeutics Market Size, Share, Trends & Forecast 2033According to the latest report published by Data Bridge Market Research, the Nanobody Therapeutics Market CAGR ValueAs per Data Bridge Market Research analysis The Nanobody Therapeutics Market was valued at USD 2.34 billion in 2025 and is projected to reach USD 7.15 billion by 2033, growing at a CAGR of 15.00% from 2026 to 2033. The market is experiencing steady growth driven by...0 Comentários 0 Compartilhamentos 23 Visualizações 0 Anterior
-
Biopharmaceutical Market to Reach USD 918.75 Billion by 2033 Fueled by Innovation in Biologics and Advanced TherapiesThe global biopharmaceutical market size was valued at USD 450.89 billion in 2024 and is estimated to grow from USD 487.99 billion in 2025 to reach USD 918.75 billion by 2033, growing at a CAGR of 8.23% during the forecast period (2025–2033). How Is the Biopharmaceutical Market Analyzed and What Research Methodology Is Used? The study examines...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Biosimilar and Biologics Market Industry Report 2036: Key Trends, Regional Insights, and Strategic DevelopmentsThe Biosimilar and Biologics Market is expected to witness robust expansion as healthcare systems worldwide increasingly adopt cost-effective biologic therapies to improve patient access and reduce treatment costs. According to Future Market Insights (FMI), the market is projected to grow from USD 604.4 million in 2026 to USD 1,257.3 million by 2036, registering a 7.6% CAGR during the forecast...0 Comentários 0 Compartilhamentos 672 Visualizações 0 Anterior
-
Biosimilar and Biologics Market Industry Report 2036: Key Trends, Regional Insights, and Strategic DevelopmentsThe Biosimilar and Biologics Market is expected to witness robust expansion as healthcare systems worldwide increasingly adopt cost-effective biologic therapies to improve patient access and reduce treatment costs. According to Future Market Insights (FMI), the market is projected to grow from USD 604.4 million in 2026 to USD 1,257.3 million by 2036, registering a 7.6% CAGR during the forecast...0 Comentários 0 Compartilhamentos 660 Visualizações 0 Anterior
-
Cancer Biologics Market to Reach USD 219.58 Billion by 2033, Growing at a CAGR of 6.7%The global Cancer Biologics Market is witnessing significant growth, driven by the increasing prevalence of cancer, advancements in biotechnology, and the rising adoption of targeted therapies. Cancer biologics, including monoclonal antibodies, vaccines, and cell-based therapies, are transforming oncology treatment by offering improved efficacy and reduced side effects compared to...0 Comentários 0 Compartilhamentos 889 Visualizações 0 Anterior
Páginas impulsionada
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek